Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

43 44 Next >

Should You Buy DexCom Stock Before Oct. 31? ↗

October 30, 2025

The company hasn't had a great year. Is it about to turn things around?

Via The Motley Fool

Topics Lawsuit

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 29, 2025

From The Schall Law Firm

Via Business Wire

An Overview of DexCom's Earnings ↗

October 29, 2025

Via Benzinga

DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the Firm

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DexCom (DXCM) Reports Earnings Tomorrow: What To Expect

October 28, 2025

Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know.

Via StockStory

DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors

October 28, 2025

From Kirby McInerney LLP

Via Business Wire

Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

October 28, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor ↗

October 28, 2025

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

Via Benzinga

Topics Death Lawsuit

Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices ↗

October 28, 2025

Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023.

Via Stocktwits

Topics Death Economy

Dexcom Appoints Euan Ashley to Board of Directors

October 27, 2025

From DexCom, Inc.

Via Business Wire

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 27, 2025

From Halper Sadeh LLC

Via Business Wire

Forecasting The Future: 13 Analyst Projections For DexCom ↗

October 21, 2025

Via Benzinga

2 Stocks Down 17% and 21% to Buy Right Now ↗

October 14, 2025

Both companies have faced recent challenges, but look likely to overcome them.

Via The Motley Fool

Topics World Trade

Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment

October 13, 2025

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Dexcom Inc (NASDAQ:DXCM) Fits the Affordable Growth Strategy with Solid Expansion and Sensible Pricing ↗

October 11, 2025

Dexcom offers strong growth in diabetes care with solid profitability and a reasonable valuation, fitting an affordable growth investment strategy.

Via Chartmill

DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm

October 07, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.

October 02, 2025

From DexCom, Inc.

Via Business Wire

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? ↗

October 01, 2025

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Stay informed with the top movers within the S&P500 index on Friday. ↗

September 26, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Forecasting The Future: 10 Analyst Projections For DexCom ↗

September 26, 2025

10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

1 Growth Stock Down 40% to Buy Hand Over Fist Right Now ↗

September 23, 2025

It is dealing with some short-term issues, but its prospects remain bright.

Via The Motley Fool

Topics World Trade

2 Mid-Cap Stocks with Promising Prospects and 1 Facing Challenges

September 23, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Topics Economy

Which Stocks Win When Rates Fall? Goldman Picks These Surprising Names ↗

September 22, 2025

Via Benzinga

Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio? ↗

September 21, 2025

Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, and downgrades.

Via Benzinga

DEXCOM INC (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy ↗

September 20, 2025

DexCom (DXCM) offers strong growth, high profitability, and reasonable valuation, fitting the "Affordable Growth" investment strategy for long-term gains.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today